• Citer

p-53 gene mutations as a predictive marker in advanced breast cancer patients randomly treated either with doxorubicin or with docetaxel

par Desmedt, Christine ;Tanner, M;Di Leo, Angelo ;Paesmans, Marianne ;Cardoso, Fatima ;Durbecq, Virginie ;Chan, S;Friedrichs, Kay;Van Belle, S.;Leroy, Jean-Yves;Sotiriou, Christos ;Larsimont, Denis ;Piccart-Gebhart, Martine ;Isola, Jorma
Référence San Antonio Breast Cancer Symposium - SABCS(26th: December 2004: San Antonio, Tx, USA), Breast Cancer Res Treat, Vol. vol 88 (suppl 1, page (S52)
Publication Publié, 2004-12

Abstract de conférence

• Détails
• Contenu

Titre:	p-53 gene mutations as a predictive marker in advanced breast cancer patients randomly treated either with doxorubicin or with docetaxel
Auteur:	Desmedt, Christine; Tanner, M; Di Leo, Angelo; Paesmans, Marianne; Cardoso, Fatima; Durbecq, Virginie; Chan, S; Friedrichs, Kay; Van Belle, S.; Leroy, Jean-Yves; Sotiriou, Christos; Larsimont, Denis; Piccart-Gebhart, Martine; Isola, Jorma
Informations sur la publication:	San Antonio Breast Cancer Symposium - SABCS(26th: December 2004: San Antonio, Tx, USA), Breast Cancer Res Treat, Vol. vol 88 (suppl 1, page (S52)
Statut de publication:	Publié, 2004-12
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais